|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4002531A
(en)
|
1976-01-22 |
1977-01-11 |
Pierce Chemical Company |
Modifying enzymes with polyethylene glycol and product produced thereby
|
|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
US5514581A
(en)
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
|
US5770697A
(en)
|
1986-11-04 |
1998-06-23 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
US6018030A
(en)
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
US5641648A
(en)
|
1986-11-04 |
1997-06-24 |
Protein Polymer Technologies, Inc. |
Methods for preparing synthetic repetitive DNA
|
|
US4863457A
(en)
|
1986-11-24 |
1989-09-05 |
Lee David A |
Drug delivery device
|
|
US4997652A
(en)
|
1987-12-22 |
1991-03-05 |
Visionex |
Biodegradable ocular implants
|
|
DE68925971T2
(de)
|
1988-09-23 |
1996-09-05 |
Cetus Oncology Corp |
Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
|
|
WO1990013540A1
(en)
|
1989-04-19 |
1990-11-15 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
FR2646437B1
(fr)
|
1989-04-28 |
1991-08-30 |
Transgene Sa |
Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
|
|
US5164188A
(en)
|
1989-11-22 |
1992-11-17 |
Visionex, Inc. |
Biodegradable ocular implants
|
|
AU8498091A
(en)
|
1990-08-02 |
1992-03-02 |
Regents Of The University Of Colorado, The |
Systematic polypeptide evolution by reverse translation
|
|
JP3051145B2
(ja)
|
1990-08-28 |
2000-06-12 |
住友製薬株式会社 |
新規なポリエチレングリコール誘導体修飾ペプチド
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
KR0185215B1
(ko)
|
1990-11-30 |
1999-05-01 |
요시다 쇼오지 |
서방성 안구삽입용 약제
|
|
US5773574A
(en)
|
1990-12-03 |
1998-06-30 |
The Scripps Research Institute |
Polypeptides for promoting cell attachment
|
|
US5235041A
(en)
|
1990-12-28 |
1993-08-10 |
Protein Polymer Technologies, Inc. |
Purification of structurally ordered recombinant protein polymers
|
|
US5792742A
(en)
|
1991-06-14 |
1998-08-11 |
New York University |
Fibrin-binding peptide fragments of fibronectin
|
|
WO1993003172A1
(en)
|
1991-08-01 |
1993-02-18 |
University Research Corporation |
Systematic polypeptide evolution by reverse translation
|
|
NZ255041A
(en)
|
1992-07-13 |
1996-11-26 |
Bionebraska Inc |
Preparation of a recombinant single copy polypeptide or portion thereof modified with a terminal alpha amino carbon reactive group and reactive side chain groups involving biologically added protective groups
|
|
EP1005870B1
(en)
|
1992-11-13 |
2009-01-21 |
Biogen Idec Inc. |
Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
WO1994017097A1
(en)
|
1993-01-19 |
1994-08-04 |
Regents Of The University Of Minnesota |
Synthetic fibronectin fragments as inhibitors of retroviral infections
|
|
ATE195065T1
(de)
|
1993-02-26 |
2000-08-15 |
Santen Pharmaceutical Co Ltd |
Biologisch abbaubarer sklerastopfen
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
AU8124694A
(en)
|
1993-10-29 |
1995-05-22 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5516522A
(en)
|
1994-03-14 |
1996-05-14 |
Board Of Supervisors Of Louisiana State University |
Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5559000A
(en)
|
1995-01-18 |
1996-09-24 |
The Scripps Research Institute |
Encoded reaction cassette
|
|
US6369116B1
(en)
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
DE19646372C1
(de)
|
1995-11-11 |
1997-06-19 |
Evotec Biosystems Gmbh |
Genotyp und Phänotyp koppelnde Verbindung
|
|
GB9618960D0
(en)
|
1996-09-11 |
1996-10-23 |
Medical Science Sys Inc |
Proteases
|
|
US5922676A
(en)
|
1996-09-20 |
1999-07-13 |
The Burnham Institute |
Methods of inhibiting cancer by using superfibronectin
|
|
EP1477561B1
(en)
|
1996-10-17 |
2008-12-10 |
Mitsubishi Chemical Corporation |
Molecule assigning genotype to phenotype and use thereof
|
|
JP3837748B2
(ja)
|
1997-01-17 |
2006-10-25 |
東亞合成株式会社 |
Ｖｅｇｆ結合性ポリペプチド
|
|
US6261804B1
(en)
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
|
ATE529509T1
(de)
|
1997-01-21 |
2011-11-15 |
Gen Hospital Corp |
Selektion von proteinen unter verwendung von rna- protein-fusionen
|
|
JP2002505574A
(ja)
|
1997-04-30 |
2002-02-19 |
エンゾン，インコーポレイテッド |
ポリアルキレンオキシド修飾された単鎖ポリペプチド
|
|
WO1998056915A2
(en)
|
1997-06-12 |
1998-12-17 |
Research Corporation Technologies, Inc. |
Artificial antibody polypeptides
|
|
US6159722A
(en)
|
1997-12-03 |
2000-12-12 |
Boehringer Mannheim Gmbh |
Chimeric serine proteases
|
|
AU3463699A
(en)
|
1998-04-03 |
1999-10-25 |
Phylos, Inc. |
Addressable protein arrays
|
|
US20030045681A1
(en)
|
1998-05-11 |
2003-03-06 |
Anthony J. Zelano |
Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
|
|
JP4108827B2
(ja)
|
1998-05-28 |
2008-06-25 |
大日本印刷株式会社 |
無機質系化粧板
|
|
AU776910B2
(en)
|
1998-12-08 |
2004-09-23 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Modifying protein immunogenicity
|
|
GB9827228D0
(en)
|
1998-12-10 |
1999-02-03 |
Univ Nottingham |
Cancer detection method and reagents
|
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
DK1137941T4
(da)
|
1998-12-10 |
2014-01-06 |
Brystol Myers Squibb Company |
Protein-scaffolds til antistof-mimetika og andre bindingsproteiner
|
|
US7115396B2
(en)
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
ES2223705T3
(es)
|
1999-04-28 |
2005-03-01 |
Board Of Regents, The University Of Texas System |
Composiciones y metodos para el tratamiento de cancer mediante inhibi cion selectiva del vegf.
|
|
EP1196637B1
(en)
|
1999-07-27 |
2007-04-25 |
Adnexus Therapeutics, Inc. |
Peptide acceptor ligation methods
|
|
US6399857B1
(en)
|
1999-09-22 |
2002-06-04 |
Paradigm Genetics, Inc. |
Modified nucleotide sequence encoding a LexA DNA binding domain optimized for arabidopsis species
|
|
JP2003528632A
(ja)
|
2000-03-31 |
2003-09-30 |
インスティティ・パスツール |
血管内皮成長因子（ｖｅｇｆ）−媒介性脈管形成を阻害するペプチド、該ペプチドをエンコードするポリヌクレオチド及びその使用方法
|
|
WO2001096559A2
(en)
|
2000-06-15 |
2001-12-20 |
Board Of Regents The University Of Texas System |
Regulatable, catalytically active nucleic acids
|
|
AU7786701A
(en)
|
2000-07-11 |
2002-01-21 |
Res Corp Technologies Inc |
Artificial antibody polypeptides
|
|
WO2002026265A2
(en)
|
2000-09-29 |
2002-04-04 |
Schering Corporation |
Pegylated interleukin-10
|
|
JP2004526419A
(ja)
|
2000-10-16 |
2004-09-02 |
フィロス インク． |
抗体模倣物および他の結合タンパク質のためのタンパク質骨格
|
|
US7598352B2
(en)
|
2000-11-17 |
2009-10-06 |
University Of Rochester |
Method of identifying polypeptide monobodies which bind to target proteins and use thereof
|
|
WO2002043785A2
(en)
|
2000-11-29 |
2002-06-06 |
Oculex Pharmaceuticals, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
|
US6509027B2
(en)
|
2001-02-12 |
2003-01-21 |
Supergen, Inc. |
Injectable pharmaceutical composition comprising coated particles of camptothecin
|
|
EP1572718A4
(en)
|
2001-04-04 |
2006-03-15 |
Univ Rochester |
ALPHA NU BETA-3 INTEGRIN BINDING POLYPEPTIDE ANTIBODY AND THEIR USE
|
|
WO2002088171A2
(en)
|
2001-04-26 |
2002-11-07 |
Avidia Research Institute |
Combinatorial libraries of monomer domains
|
|
US20030004561A1
(en)
|
2001-06-28 |
2003-01-02 |
Steve Bigus |
Peeling sheath for self-expanding stent
|
|
WO2003022858A2
(de)
|
2001-09-11 |
2003-03-20 |
Nascacell Gmbh |
Verfahren zum screenen von inhibitoren für die protein-protein-wechselwirkung sowie ribozyme hierzu
|
|
US20080193445A1
(en)
|
2002-01-18 |
2008-08-14 |
Liliane Goetsch |
Novel anti-IGF-IR antibodies and uses thereof
|
|
SG161101A1
(en)
|
2002-02-22 |
2010-05-27 |
Schering Corp |
Pharmaceutical formulations of antineoplastic agents, in particular temozolomide processes of making and using the same
|
|
ATE475431T1
(de)
|
2002-03-04 |
2010-08-15 |
Imclone Llc |
Kdr-spezifische humane antikörper und deren anwendung
|
|
WO2003104418A2
(en)
|
2002-06-06 |
2003-12-18 |
Research Corporation Technologies, Inc. |
Reconstituted polypeptides
|
|
US20070178082A1
(en)
|
2002-11-08 |
2007-08-02 |
Ablynx N.V. |
Stabilized single domain antibodies
|
|
US7053701B2
(en)
|
2003-11-04 |
2006-05-30 |
Vice Michael W |
Power amplifier output stage with multiple power states and improved efficiency
|
|
WO2005047714A1
(en)
|
2003-11-17 |
2005-05-26 |
Telezygology Inc |
Fasteners and other assemblies
|
|
JP5006651B2
(ja)
|
2003-12-05 |
2012-08-22 |
ブリストル−マイヤーズ スクウィブ カンパニー |
２型血管内皮増殖因子受容体の阻害剤
|
|
US20080220049A1
(en)
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
|
US20070059336A1
(en)
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
US20060182783A1
(en)
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US20050244472A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
|
JP2008512352A
(ja)
|
2004-07-17 |
2008-04-24 |
イムクローン システムズ インコーポレイティド |
新規な四価の二重特異性抗体
|
|
US7597884B2
(en)
*
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
EP1804751A2
(en)
|
2004-10-04 |
2007-07-11 |
QLT USA, Inc. |
Ocular delivery of polymeric delivery formulations
|
|
CA2589484A1
(en)
|
2004-12-02 |
2006-06-08 |
Schering Corporation |
Methods of using temozolomide formulation intrathecally in the treatment of cancers
|
|
EP1853309A4
(en)
|
2005-02-23 |
2008-10-22 |
Merrimack Pharmaceuticals Inc |
BISPECIFIC BINDER FOR MODULATING BIOLOGICAL ACTIVITY
|
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US7887273B2
(en)
|
2005-09-15 |
2011-02-15 |
Newfrey Llc |
Blind rivet and method
|
|
US20070072933A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an ocular agent
|
|
US8097438B2
(en)
*
|
2005-10-07 |
2012-01-17 |
The Regents Of The University Of California |
Nucleic acids encoding modified cytochrome P450 enzymes and methods of use thereof
|
|
MX339797B
(es)
|
2005-10-18 |
2016-06-10 |
Allergan Inc |
Terapia ocular que usa derivados glucocorticoides que penetran selectivamente los tejidos del segmento posterior.
|
|
WO2007053807A2
(en)
|
2005-10-31 |
2007-05-10 |
Wisconsin Alumni Research Foundation |
Calcitriol for treating intraocular diseases associated with angiogenesis
|
|
CN101356271A
(zh)
|
2005-11-09 |
2009-01-28 |
拜耳先灵医药股份有限公司 |
功能阻断性抗-ed-b-纤连蛋白抗体的鉴别与鉴定
|
|
ME00380B
(me)
*
|
2005-11-23 |
2011-10-10 |
Acceleron Pharma Inc |
Amtagonisti aktivin-actriia i primjene za stimulaciju rasta kosti
|
|
JP2009531283A
(ja)
|
2006-02-02 |
2009-09-03 |
アラーガン、インコーポレイテッド |
眼系疾患の処置のための組成物および方法
|
|
CN101384279B
(zh)
*
|
2006-02-24 |
2012-02-22 |
奇斯药制品公司 |
抗淀粉样蛋白免疫原性组合物、方法和用途
|
|
AU2007241405A1
(en)
*
|
2006-04-21 |
2007-11-01 |
Transgene S.A. |
HPV-18-based papillomavirus vaccine
|
|
US20070269422A1
(en)
|
2006-05-17 |
2007-11-22 |
Ablynx N.V. |
Serum albumin binding proteins with long half-lives
|
|
WO2008019290A2
(en)
|
2006-08-04 |
2008-02-14 |
Astrazeneca Ab |
Human antibodies to erbb 2
|
|
WO2008031098A1
(en)
|
2006-09-09 |
2008-03-13 |
The University Of Chicago |
Binary amino acid libraries for fibronectin type iii polypeptide monobodies
|
|
JP2010507099A
(ja)
*
|
2006-10-16 |
2010-03-04 |
ザ アリゾナ ボード オブ リージェンツ ア ボディ コーポレイト オブ ザ ステイト オブ アリゾナ アクティング フォー アンド オン ビハーフ オブ アリゾナ ステイト ユニバーシティー |
合成抗体
|
|
EP2121743B1
(en)
*
|
2006-11-22 |
2015-06-03 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
|
|
US8476243B2
(en)
*
|
2006-12-29 |
2013-07-02 |
Transderm, Inc. |
Methods and compositions for treating keratin hyperproliferative disorders
|
|
ATE516814T1
(de)
|
2007-02-02 |
2011-08-15 |
Bristol Myers Squibb Co |
10fn3 domain zur behandlung von krankheiten begleitet von unerwünschter angiogenese
|
|
WO2008108986A2
(en)
|
2007-03-02 |
2008-09-12 |
Amgen Inc. |
Methods and compositions for treating tumor diseases
|
|
US11078262B2
(en)
|
2007-04-30 |
2021-08-03 |
Allergan, Inc. |
High viscosity macromolecular compositions for treating ocular conditions
|
|
JP5591691B2
(ja)
|
2007-05-22 |
2014-09-17 |
アムジエン・インコーポレーテツド |
生物活性を有する融合タンパク質を作製するための組成物及び方法
|
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
|
EP2222846B1
(en)
|
2007-08-10 |
2017-05-03 |
Protelix, Inc. |
Universal fibronectin type iii binding-domain libraries
|
|
US8680019B2
(en)
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
|
EP2197476A2
(en)
|
2007-08-20 |
2010-06-23 |
Bristol-Myers Squibb Company |
Use of vegfr-2 inhibitors for treating metastatic cancer
|
|
JP5496897B2
(ja)
|
2007-10-04 |
2014-05-21 |
ザイモジェネティクス， インコーポレイテッド |
Ｂ７ファミリーメンバーのｚＢ７Ｈ６ならびに関連する組成物および方法
|
|
MX2010004374A
(es)
|
2007-10-31 |
2010-04-30 |
Medimmune Llc |
Armazones proteinicos.
|
|
WO2009073115A1
(en)
|
2007-11-28 |
2009-06-11 |
Bristol-Myers Squibb Company |
Combination vegfr2 therapy with mtor inhibitors
|
|
CA2709994A1
(en)
|
2007-12-19 |
2009-07-09 |
Centocor Ortho Biotech Inc. |
Non-antibody scaffold protein fusions phage display via fusion to pix of m13 phage
|
|
EA201000979A1
(ru)
|
2007-12-27 |
2011-02-28 |
Новартис Аг |
Улучшенные связывающие молекулы на основе фибронектина и их применение
|
|
KR20100128291A
(ko)
|
2008-02-14 |
2010-12-07 |
브리스톨-마이어스 스큅 컴퍼니 |
Ｅｇｆｒ에 결합하는 조작된 단백질을 기초로 하는 표적화된 치료제
|
|
CN102076713B
(zh)
|
2008-05-02 |
2015-03-25 |
诺华股份有限公司 |
改进的基于纤连蛋白的结合分子及其用途
|
|
CN102099373A
(zh)
|
2008-05-22 |
2011-06-15 |
百时美施贵宝公司 |
基于纤连蛋白的多价支架结构域蛋白
|
|
BRPI0919881B1
(pt)
|
2008-10-31 |
2021-09-08 |
Centocor Ortho Biotech Inc |
Proteína de arcabouço e seu método de geração, biblioteca e seu método de construção, molécula de ácido nucleico, vetor de ácido nucleico, célula hospedeira, composição, dispositivo médico e artigo de fabricação
|
|
US8415291B2
(en)
|
2008-10-31 |
2013-04-09 |
Centocor Ortho Biotech Inc. |
Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses
|
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
|
|
US20110275535A1
(en)
|
2008-12-16 |
2011-11-10 |
Novartis Ag |
Yeast Display Systems
|
|
EP2396000A1
(en)
|
2009-02-11 |
2011-12-21 |
Bristol-Myers Squibb Company |
Combination vegfr2 therapy with temozolomide
|
|
BRPI1008532B1
(pt)
|
2009-02-12 |
2021-12-14 |
Janssen Biotech, Inc |
Arcabouço de proteína isolada, método para construção de uma biblioteca de arcabouço de proteína isolada, molécula de ácido nucleico isolada, vetor de ácido nucleico isolado, célula hospedeira de bactéria ou fungo, composição, dispositivo médico e artigo de manufatura para uso farmacêutico ou de diagnóstico em seres humanos
|
|
US8067201B2
(en)
*
|
2009-04-17 |
2011-11-29 |
Bristol-Myers Squibb Company |
Methods for protein refolding
|
|
US20120270797A1
(en)
|
2009-08-13 |
2012-10-25 |
Massachusetts Institute Of Technology |
Engineered proteins including mutant fibronectin domains
|
|
EP3434769B1
(en)
|
2009-10-30 |
2020-11-25 |
Novartis AG |
Universal fibronectin type iii bottom-side binding domain libraries
|
|
WO2011051466A1
(en)
|
2009-11-02 |
2011-05-05 |
Novartis Ag |
Anti-idiotypic fibronectin-based binding molecules and uses thereof
|
|
US20110123545A1
(en)
|
2009-11-24 |
2011-05-26 |
Bristol-Myers Squibb Company |
Combination of vegfr2 and igf1r inhibitors for the treatment of proliferative diseases
|
|
WO2011092233A1
(en)
|
2010-01-29 |
2011-08-04 |
Novartis Ag |
Yeast mating to produce high-affinity combinations of fibronectin-based binders
|
|
WO2011100700A2
(en)
|
2010-02-12 |
2011-08-18 |
University Of Rochester |
Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies
|
|
BR112012019881A2
(pt)
|
2010-02-18 |
2017-06-27 |
Bristol Myers Squibb Co |
proteínas de domínio estrutural baseadas na fibronectina que ligam-se à il-23
|
|
ES2755398T3
(es)
|
2010-04-13 |
2020-04-22 |
Medimmune Llc |
Andamios multiméricos específicos de TRAIL R2
|
|
KR20130056871A
(ko)
|
2010-04-13 |
2013-05-30 |
브리스톨-마이어스 스큅 컴퍼니 |
Ｐｃｓｋ９에 결합하는 피브로넥틴 기반 스캐폴드 도메인 단백질
|
|
EP3103478B1
(en)
|
2010-04-30 |
2019-04-17 |
Janssen Biotech, Inc. |
Stabilized fibronectin domain compositions, methods and uses
|
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
|
ES2573108T3
(es)
|
2010-05-26 |
2016-06-06 |
Bristol-Myers Squibb Company |
Proteínas de armazón a base de fibronectina que tienen estabilidad mejorada
|
|
CA2805862A1
(en)
|
2010-07-30 |
2012-02-02 |
Novartis Ag |
Fibronectin cradle molecules and libraries thereof
|
|
WO2012088006A1
(en)
|
2010-12-22 |
2012-06-28 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind il-23
|
|
EP2697257B1
(en)
|
2011-04-13 |
2016-10-19 |
Bristol-Myers Squibb Company |
Fc fusion proteins comprising novel linkers or arrangements
|
|
US20140187488A1
(en)
|
2011-05-17 |
2014-07-03 |
Bristol-Myers Squibb Company |
Methods for maintaining pegylation of polypeptides
|
|
EP2710382B1
(en)
|
2011-05-17 |
2017-10-18 |
Bristol-Myers Squibb Company |
Improved methods for the selection of binding proteins
|
|
MX387605B
(es)
|
2011-09-27 |
2025-03-18 |
Janssen Biotech Inc |
Supercontigos de proteina basados en repeticiones de fibronectina tipo iii con superficies de union alternativas
|